ID   VLDLR_RAT               Reviewed;         873 AA.
AC   P98166;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 1.
DT   02-OCT-2024, entry version 161.
DE   RecName: Full=Very low-density lipoprotein receptor;
DE            Short=VLDL receptor;
DE            Short=VLDL-R;
DE   Flags: Precursor;
GN   Name=Vldlr;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RX   PubMed=7929362; DOI=10.1016/s0021-9258(18)47209-2;
RA   Jokinen E.V., Landschulz K.T., Wyne K.L., Ho Y.K., Frykman P.K.,
RA   Hobbs H.H.;
RT   "Regulation of the very low density lipoprotein receptor by thyroid hormone
RT   in rat skeletal muscle.";
RL   J. Biol. Chem. 269:26411-26418(1994).
CC   -!- FUNCTION: Multifunctional cell surface receptor that binds VLDL and
CC       transports it into cells by endocytosis and therefore plays an
CC       important role in energy metabolism. Binds also to a wide range of
CC       other molecules including Reelin/RELN or apolipoprotein E/APOE-
CC       containing ligands as well as clusterin/CLU. In the off-state of the
CC       pathway, forms homooligomers or heterooligomers with LRP8. Upon binding
CC       to ligands, homooligomers are rearranged to higher order receptor
CC       clusters that transmit the extracellular RELN signal to intracellular
CC       signaling processes by binding to DAB1 (By similarity). This
CC       interaction results in phosphorylation of DAB1 leading to the ultimate
CC       cell responses required for the correct positioning of newly generated
CC       neurons. Later, mediates a stop signal for migrating neurons,
CC       preventing them from entering the marginal zone (By similarity).
CC       {ECO:0000250|UniProtKB:P98155, ECO:0000250|UniProtKB:P98156}.
CC   -!- SUBUNIT: Homooligomer. Binds to the extracellular matrix protein
CC       Reelin/RELN. Interacts with LRP8 (By similarity). Interacts with
CC       LDLRAP1 (By similarity). Interacts with SNX17 (By similarity).
CC       Interacts with DAB1. Interacts with PCSK9. Interacts with PAFAH1B3 and
CC       PAFAH1B2, the catalytic complex of (PAF-AH (I)) heterotetrameric
CC       enzyme; these interactions may modulate the Reelin pathway. Interacts
CC       with STX5; this interaction mediates VLDLR translocation from the
CC       endoplasmic reticulum to the plasma membrane. Interacts with CLU (By
CC       similarity). {ECO:0000250|UniProtKB:P98155,
CC       ECO:0000250|UniProtKB:P98156}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane protein.
CC       Membrane, clathrin-coated pit; Single-pass type I membrane protein.
CC   -!- TISSUE SPECIFICITY: Abundant in soleus, gastrocnemicus, heart muscle,
CC       placenta, brain, lung and white fat. Less in aorta, ovary, kidney,
CC       spleen, adrenal gland and thymus.
CC   -!- PTM: Ubiquitinated at Lys-839 by MYLIP leading to degradation.
CC       {ECO:0000250}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L35767; AAA42341.1; -; mRNA.
DR   AlphaFoldDB; P98166; -.
DR   SMR; P98166; -.
DR   STRING; 10116.ENSRNOP00000036229; -.
DR   GlyCosmos; P98166; 3 sites, No reported glycans.
DR   GlyGen; P98166; 3 sites.
DR   PhosphoSitePlus; P98166; -.
DR   jPOST; P98166; -.
DR   PaxDb; 10116-ENSRNOP00000036229; -.
DR   UCSC; RGD:3963; rat.
DR   AGR; RGD:3963; -.
DR   RGD; 3963; Vldlr.
DR   eggNOG; KOG1215; Eukaryota.
DR   InParanoid; P98166; -.
DR   PhylomeDB; P98166; -.
DR   Reactome; R-RNO-8866376; Reelin signalling pathway.
DR   Reactome; R-RNO-8866427; VLDLR internalisation and degradation.
DR   Reactome; R-RNO-8964046; VLDL clearance.
DR   PRO; PR:P98166; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0045177; C:apical part of cell; IDA:RGD.
DR   GO; GO:0009986; C:cell surface; IDA:RGD.
DR   GO; GO:0005905; C:clathrin-coated pit; IEA:UniProtKB-SubCell.
DR   GO; GO:0005615; C:extracellular space; ISO:RGD.
DR   GO; GO:0098978; C:glutamatergic synapse; ISO:RGD.
DR   GO; GO:0016020; C:membrane; ISO:RGD.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:RGD.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0043235; C:receptor complex; ISO:RGD.
DR   GO; GO:0045202; C:synapse; ISO:RGD.
DR   GO; GO:0034361; C:very-low-density lipoprotein particle; IEA:UniProtKB-KW.
DR   GO; GO:0034185; F:apolipoprotein binding; ISO:RGD.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0048306; F:calcium-dependent protein binding; ISO:RGD.
DR   GO; GO:0038024; F:cargo receptor activity; ISO:RGD.
DR   GO; GO:0030296; F:protein tyrosine kinase activator activity; TAS:RGD.
DR   GO; GO:0038025; F:reelin receptor activity; ISO:RGD.
DR   GO; GO:0034189; F:very-low-density lipoprotein particle binding; ISO:RGD.
DR   GO; GO:0030229; F:very-low-density lipoprotein particle receptor activity; ISS:BHF-UCL.
DR   GO; GO:0007166; P:cell surface receptor signaling pathway; TAS:RGD.
DR   GO; GO:0042149; P:cellular response to glucose starvation; IEP:RGD.
DR   GO; GO:0071456; P:cellular response to hypoxia; IDA:RGD.
DR   GO; GO:0032869; P:cellular response to insulin stimulus; IEP:RGD.
DR   GO; GO:0071347; P:cellular response to interleukin-1; IEP:RGD.
DR   GO; GO:0071222; P:cellular response to lipopolysaccharide; IEP:RGD.
DR   GO; GO:0021987; P:cerebral cortex development; IEP:RGD.
DR   GO; GO:0008203; P:cholesterol metabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0048813; P:dendrite morphogenesis; ISO:RGD.
DR   GO; GO:0034436; P:glycoprotein transport; ISO:RGD.
DR   GO; GO:0007507; P:heart development; IEP:RGD.
DR   GO; GO:0006869; P:lipid transport; IEA:UniProtKB-KW.
DR   GO; GO:1900006; P:positive regulation of dendrite development; ISO:RGD.
DR   GO; GO:0006898; P:receptor-mediated endocytosis; ISO:RGD.
DR   GO; GO:0038026; P:reelin-mediated signaling pathway; ISO:RGD.
DR   GO; GO:0051963; P:regulation of synapse assembly; ISO:RGD.
DR   GO; GO:0009725; P:response to hormone; IEP:RGD.
DR   GO; GO:0001666; P:response to hypoxia; IEP:RGD.
DR   GO; GO:0032496; P:response to lipopolysaccharide; IEP:RGD.
DR   GO; GO:0007584; P:response to nutrient; IEP:RGD.
DR   GO; GO:0009410; P:response to xenobiotic stimulus; IEP:RGD.
DR   GO; GO:0021517; P:ventral spinal cord development; ISO:RGD.
DR   GO; GO:0034447; P:very-low-density lipoprotein particle clearance; ISS:BHF-UCL.
DR   CDD; cd00054; EGF_CA; 1.
DR   CDD; cd00112; LDLa; 8.
DR   Gene3D; 2.10.25.10; Laminin; 3.
DR   Gene3D; 4.10.400.10; Low-density Lipoprotein Receptor; 8.
DR   Gene3D; 2.120.10.30; TolB, C-terminal domain; 1.
DR   InterPro; IPR011042; 6-blade_b-propeller_TolB-like.
DR   InterPro; IPR001881; EGF-like_Ca-bd_dom.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR000152; EGF-type_Asp/Asn_hydroxyl_site.
DR   InterPro; IPR018097; EGF_Ca-bd_CS.
DR   InterPro; IPR009030; Growth_fac_rcpt_cys_sf.
DR   InterPro; IPR036055; LDL_receptor-like_sf.
DR   InterPro; IPR050685; LDLR.
DR   InterPro; IPR023415; LDLR_class-A_CS.
DR   InterPro; IPR000033; LDLR_classB_rpt.
DR   InterPro; IPR002172; LDrepeatLR_classA_rpt.
DR   InterPro; IPR049883; NOTCH1_EGF-like.
DR   PANTHER; PTHR24270; LOW-DENSITY LIPOPROTEIN RECEPTOR-RELATED; 1.
DR   PANTHER; PTHR24270:SF8; VERY LOW-DENSITY LIPOPROTEIN RECEPTOR; 1.
DR   Pfam; PF07645; EGF_CA; 1.
DR   Pfam; PF14670; FXa_inhibition; 2.
DR   Pfam; PF00057; Ldl_recept_a; 8.
DR   Pfam; PF00058; Ldl_recept_b; 5.
DR   PRINTS; PR00261; LDLRECEPTOR.
DR   SMART; SM00181; EGF; 6.
DR   SMART; SM00179; EGF_CA; 2.
DR   SMART; SM00192; LDLa; 8.
DR   SMART; SM00135; LY; 5.
DR   SUPFAM; SSF57184; Growth factor receptor domain; 1.
DR   SUPFAM; SSF57424; LDL receptor-like module; 8.
DR   SUPFAM; SSF63825; YWTD domain; 1.
DR   PROSITE; PS00010; ASX_HYDROXYL; 2.
DR   PROSITE; PS01186; EGF_2; 3.
DR   PROSITE; PS50026; EGF_3; 2.
DR   PROSITE; PS01187; EGF_CA; 1.
DR   PROSITE; PS01209; LDLRA_1; 8.
DR   PROSITE; PS50068; LDLRA_2; 8.
DR   PROSITE; PS51120; LDLRB; 5.
PE   2: Evidence at transcript level;
KW   Cholesterol metabolism; Coated pit; Disulfide bond; EGF-like domain;
KW   Endocytosis; Glycoprotein; Isopeptide bond; Lipid metabolism;
KW   Lipid transport; Membrane; Receptor; Reference proteome; Repeat; Signal;
KW   Steroid metabolism; Sterol metabolism; Transmembrane; Transmembrane helix;
KW   Transport; Ubl conjugation; VLDL.
FT   SIGNAL          1..27
FT                   /evidence="ECO:0000255"
FT   CHAIN           28..873
FT                   /note="Very low-density lipoprotein receptor"
FT                   /id="PRO_0000017346"
FT   TOPO_DOM        28..797
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        798..819
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        820..873
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          31..69
FT                   /note="LDL-receptor class A 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00124"
FT   DOMAIN          70..110
FT                   /note="LDL-receptor class A 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00124"
FT   DOMAIN          111..151
FT                   /note="LDL-receptor class A 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00124"
FT   DOMAIN          152..190
FT                   /note="LDL-receptor class A 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00124"
FT   DOMAIN          191..231
FT                   /note="LDL-receptor class A 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00124"
FT   DOMAIN          237..275
FT                   /note="LDL-receptor class A 6"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00124"
FT   DOMAIN          276..314
FT                   /note="LDL-receptor class A 7"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00124"
FT   DOMAIN          316..355
FT                   /note="LDL-receptor class A 8"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00124"
FT   DOMAIN          356..395
FT                   /note="EGF-like 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          396..435
FT                   /note="EGF-like 2; calcium-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   REPEAT          439..480
FT                   /note="LDL-receptor class B 1"
FT   REPEAT          481..524
FT                   /note="LDL-receptor class B 2"
FT   REPEAT          525..567
FT                   /note="LDL-receptor class B 3"
FT   REPEAT          568..611
FT                   /note="LDL-receptor class B 4"
FT   REPEAT          612..654
FT                   /note="LDL-receptor class B 5"
FT   REPEAT          655..697
FT                   /note="LDL-receptor class B 6"
FT   DOMAIN          702..750
FT                   /note="EGF-like 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   REGION          751..790
FT                   /note="Clustered O-linked oligosaccharides"
FT   MOTIF           832..837
FT                   /note="Endocytosis signal"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        151
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        765
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        781
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        33..45
FT                   /evidence="ECO:0000250"
FT   DISULFID        40..58
FT                   /evidence="ECO:0000250"
FT   DISULFID        52..67
FT                   /evidence="ECO:0000250"
FT   DISULFID        72..84
FT                   /evidence="ECO:0000250"
FT   DISULFID        79..97
FT                   /evidence="ECO:0000250"
FT   DISULFID        91..108
FT                   /evidence="ECO:0000250"
FT   DISULFID        113..127
FT                   /evidence="ECO:0000250"
FT   DISULFID        120..140
FT                   /evidence="ECO:0000250"
FT   DISULFID        134..149
FT                   /evidence="ECO:0000250"
FT   DISULFID        154..166
FT                   /evidence="ECO:0000250"
FT   DISULFID        161..179
FT                   /evidence="ECO:0000250"
FT   DISULFID        173..188
FT                   /evidence="ECO:0000250"
FT   DISULFID        193..205
FT                   /evidence="ECO:0000250"
FT   DISULFID        200..218
FT                   /evidence="ECO:0000250"
FT   DISULFID        212..229
FT                   /evidence="ECO:0000250"
FT   DISULFID        239..251
FT                   /evidence="ECO:0000250"
FT   DISULFID        246..264
FT                   /evidence="ECO:0000250"
FT   DISULFID        258..273
FT                   /evidence="ECO:0000250"
FT   DISULFID        278..290
FT                   /evidence="ECO:0000250"
FT   DISULFID        285..303
FT                   /evidence="ECO:0000250"
FT   DISULFID        297..312
FT                   /evidence="ECO:0000250"
FT   DISULFID        318..331
FT                   /evidence="ECO:0000250"
FT   DISULFID        326..344
FT                   /evidence="ECO:0000250"
FT   DISULFID        338..355
FT                   /evidence="ECO:0000250"
FT   DISULFID        360..371
FT                   /evidence="ECO:0000250"
FT   DISULFID        367..380
FT                   /evidence="ECO:0000250"
FT   DISULFID        382..394
FT                   /evidence="ECO:0000250"
FT   DISULFID        400..410
FT                   /evidence="ECO:0000250"
FT   DISULFID        406..419
FT                   /evidence="ECO:0000250"
FT   DISULFID        421..434
FT                   /evidence="ECO:0000250"
FT   DISULFID        706..719
FT                   /evidence="ECO:0000250"
FT   DISULFID        715..734
FT                   /evidence="ECO:0000250"
FT   DISULFID        736..749
FT                   /evidence="ECO:0000250"
FT   CROSSLNK        839
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000250|UniProtKB:P98155"
SQ   SEQUENCE   873 AA;  96542 MW;  E521D08314F2726B CRC64;
     MGTSARWALW LLLALCWAPR DSGATASGKK AKCDSSQFQC TNGRCITLLW KCDGDEDCTD
     GSDEKNCVKK TCAESDFVCK NGQCVPNRWQ CDGDPDCEDG SDESPEQCHM RTCRINEISC
     GARSTQCIPE SWRCDGENDC DNGEDEENCG NITCSADEFT CSSGRCVSRN FVCNGQDDCD
     DGSDELDCAP PTCGAHEFQC RTSSCIPLSW VCDDDADCSD QSDESLEQCG RQPVIHTKCP
     TSEIQCGSGE CIHKKWRCDG DPDCKDGSDE VNCPSRTCRP DQFECEDGSC IHGSRQCNGI
     RDCVDGSDEV NCKNVNQCLG PGKFKCRSGE CIDITKVCDQ EQDCRDWSDE PLKECHINEC
     LVNNGGCSHI CKDLVIGYEC DCAAGFELID RKTCGDIDEC QNPGICSQIC INLKGGYKCE
     CSRGYQMDLA TGVCKAVGKE PSLIFTNRRD IRKIGLERKE YIQLVEQLRN TVALDADIAA
     QKLFWADLSQ KAIFSASIDD KVGRHFKMID NVYNPAAIAV DWVYKTIYWT DAASKTISVA
     TLDGTKRKFL FNSDLREPAS IAVDPLSGFV YWSDWGEPAK IEKAGMNGFD RRPLVTEDIQ
     WPNGITLDLV KSRLYWLDSK LHMLSSVDLN GQDRRIVLKS LEFLAHPLAL TIFEDRVYWI
     DGENEAVYGA NKFTGSELAT LVNNLNDAQD IIIYHELVQP SGKNWCEEDM ENGGCEYLCL
     PAPQINDHSP KYTCSCPNGY NLEENGRECQ STSTPVTYSE TKDVNTTDIL RTSGLVPGGI
     NVTTAVSEVS VPPKGTSAAW AILPLLLLVM AAVGGYLMWR NWQHKNMKSM NFDNPVYLKT
     TEEDLSIDIG RHSASVGHTY PAISVVSTDD DLA
//
